0
     

Report Added
Report already added
Global Nanomedicine Market, By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes), By Nanoparticle Type (Polymer-based, Lipid-based, Nanocrystals, Inorganic, Others), By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others) By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others), By Region and Competition Forecast & Opportunities, 2027

Global Nanomedicine Market, By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes), By Nanoparticle Type (Polymer-based, Lipid-based, Nanocrystals, Inorganic, Others), By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others) By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others), By Region and Competition Forecast & Opportunities, 2027

The global nanomedicine market is expected to grow at an impressive CAGR of 8.28% in the forecast period, 2023-2027, to reach USD242655.19 million by 2027. The market is driven by the factors such as the growing healthcare expenditure and increased demand for personalized medicines. The massive prevalence of chronic and lifestyle disorders such as cancer and cardiovascular diseases across the globe is accelerating the application of nanomedicine in various healthcare applications. Also, the high-end investments in research and development activities by public and private players to find novel solutions for drug delivery and increase the effectiveness of drugs are expected to create lucrative growth opportunities for the global nanomedicine market in the forecast period.
Nanomedicines are considered very effective in treating chronic diseases such as cancer, dementia, and diabetes as they fuel the metabolism of medications in the body. They deliver the drugs at the target site in the right proportion. The market's availability of nanomedical products such as DNA probes, nanosensors, and nanoparticle-based imaging agents is increasing the demand. However, the high cost associated with the nanomedicine manufacturing process and research and development activities may hinder the global nanomedicine market in the forecast period.
The global nanomedicine market is divided into nano molecule type, nanoparticles type, application, disease indication, regional distribution, and competitive landscape. Based on application, the nanomedicine market is divided into drug delivery, vaccines, diagnostic imaging, regenerative medicine, and others. Drug delivery applications dominated the market in 2021 and captured 30.23% of the overall market share. This segment is expected to maintain its dominance over the next five years. The rise in awareness about the benefits of nanomedicine in drug delivery applications and the increased prevalence of diseases drives the demand for nanomedicines for drug delivery applications.
The major market players operating in the global nanomedicine market are Pfizer Inc., Janssen Pharmaceuticals, Sanofi S.A., Amgen Inc., Moderna, Inc., Novo Nordisk A/S, Genentech, Inc., Celgene Corporation, Vifor Pharma Group, Teva Pharmaceutical Industries Ltd., among others.

Years considered for this report:
Historical Years: 2017-2020
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2023-2027

Objective of the Study:
•To analyze the historical growth and the market size of the global nanomedicine market from 2017 to 2021.
•To estimate and forecast the market size of the global nanomedicine market from 2023 to 2027 and growth rate until 2027.
•To classify and forecast the global nanomedicine market is divided into nanomolecule type, nanoparticles type, application, disease indication, regional distribution, and competitive landscape.
•To identify drivers and challenges for the global nanomedicine market.
•To examine competitive developments such as expansions, new product launches, mergers, and acquisitions, etc., in the global nanomedicine market.
•To conduct pricing analysis for the global nanomedicine market.
•To identify and analyze the profile of leading players operating in global nanomedicine market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of leading nanomedicine manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the nanomedicine manufacturers who could not be identified due to the limitations of secondary research. TechSci Research analyzed the nanomedicine manufacturers, distribution channels and presence of all major players operating in the global nanomedicine market all over the world.
TechSci Research calculated the global nanomedicine market size using a bottom-up approach, where data for various regions was recorded and forecasted for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:
•Nanomedicine manufacturers/ suppliers/ distributors
•Government bodies such as regulating authorities and policy makers
•Organizations, forums, and alliances related to nanomedicine
•Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for industry stakeholders such as nanomedicine manufacturers, suppliers, distributors, and other stakeholders. The report would enable the stakeholders in strategizing investments and capitalizing on emerging market opportunities.


Report Scope:
In this report, global nanomedicine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
•Nanomedicine Market, By Nanomolecule Type:
oNanoparticles
oNanoshells
oNanodevices
oNanotubes
•Nanomedicine Market, By Nanoparticles Type:
oPolymer-based
oLipid-based
oNanocrystals
oInorganic
oOthers
•Nanomedicine Market, By Application:
oDrug Delivery
oVaccines
oDiagnostic Imaging
oRegenerative Medicine
oOthers
•Nanomedicine Market, By Disease Indication:
oOncological Diseases
oInfectious Diseases
oOrthopedic Disorders
oCardiovascular Diseases
oOthers
•Nanomedicine Market, By Region:
oNorth America
United States
Canada
Mexico
oEurope
Germany
France
United Kingdom
Italy
Spain
Denmark
oAsia Pacific
China
Japan
India
Australia
South Korea
Malaysia
Vietnam
oSouth America
Brazil
Argentina
Colombia
oMiddle East & Africa
Turkey
Israel
South Africa
Saudi Arabia
UAE
Kuwait

Competitive Landscape

Company Profiles:
Detailed analysis of the major companies present in global nanomedicine market.

Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information
•Detailed analysis and profiling of additional market players (up to five).
Table of Contents

1. Product Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19 on Global Nanomedicine Market
5. Voice of Customer
5.1. Factors Increasing the demand for Nanomedicine
5.2. Preference, By Nanomolecule Type
5.3. Demand for Nanomedicine, By Indication
5.4. Brand Awareness
6. Global Nanomedicine Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)
6.2.1.1. By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others)
6.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)
6.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)
6.2.4. By Company (2021)
6.2.5. By Region
6.3. Market Map
7. North America Nanomedicine Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)
7.2.1.1. By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others)
7.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)
7.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)
7.2.4. By Country
7.3. North America: Country Analysis
7.3.1. United States Nanomedicine Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Nanomolecule Type
7.3.1.2.1.1. By Nanoparticle Type
7.3.1.2.2. By Application
7.3.1.2.3. By Disease Indication
7.3.2. Canada Nanomedicine Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Nanomolecule Type
7.3.2.2.1.1. By Nanoparticle Type
7.3.2.2.2. By Application
7.3.2.2.3. By Disease Indication
7.3.3. Mexico Nanomedicine Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Nanomolecule Type
7.3.3.2.1.1. By Nanoparticle Type
7.3.3.2.2. By Application
7.3.3.2.3. By Disease Indication
8. Europe Nanomedicine Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)
8.2.1.1. By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others)
8.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)
8.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)
8.2.4. By Country
8.3. Europe: Country Analysis
8.3.1. Germany Nanomedicine Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Nanomolecule Type
8.3.1.2.1.1. By Nanoparticle Type
8.3.1.2.2. By Application
8.3.1.2.3. By Disease Indication
8.3.2. France Nanomedicine Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Nanomolecule Type
8.3.2.2.1.1. By Nanoparticle Type
8.3.2.2.2. By Application
8.3.2.2.3. By Disease Indication
8.3.3. United Kingdom Nanomedicine Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Nanomolecule Type
8.3.3.2.1.1. By Nanoparticle Type
8.3.3.2.2. By Application
8.3.3.2.3. By Disease Indication
8.3.4. Italy Nanomedicine Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Nanomolecule Type
8.3.4.2.1.1. By Nanoparticle Type
8.3.4.2.2. By Application
8.3.4.2.3. By Disease Indication
8.3.5. Spain Nanomedicine Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Nanomolecule Type
8.3.5.2.1.1. By Nanoparticle Type
8.3.5.2.2. By Application
8.3.5.2.3. By Disease Indication
8.3.6. Denmark Nanomedicine Market Outlook
8.3.6.1. Market Size & Forecast
8.3.6.1.1. By Value
8.3.6.2. Market Share & Forecast
8.3.6.2.1. By Nanomolecule Type
8.3.6.2.1.1. By Nanoparticle Type
8.3.6.2.2. By Application
8.3.6.2.3. By Disease Indication
9. Asia Pacific Nanomedicine Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)
9.2.1.1. By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others)
9.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)
9.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)
9.2.4. By Country
9.3. Asia Pacific: Country Analysis
9.3.1. China Nanomedicine Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Nanomolecule Type
9.3.1.2.1.1. By Nanoparticle Type
9.3.1.2.2. By Application
9.3.1.2.3. By Disease Indication
9.3.2. Japan Nanomedicine Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Nanomolecule Type
9.3.2.2.1.1. By Nanoparticle Type
9.3.2.2.2. By Application
9.3.2.2.3. By Disease Indication
9.3.3. India Nanomedicine Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Nanomolecule Type
9.3.3.2.1.1. By Nanoparticle Type
9.3.3.2.2. By Application
9.3.3.2.3. By Disease Indication
9.3.4. Australia Nanomedicine Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Nanomolecule Type
9.3.4.2.1.1. By Nanoparticle Type
9.3.4.2.2. By Application
9.3.4.2.3. By Disease Indication
9.3.5. South Korea Nanomedicine Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Nanomolecule Type
9.3.5.2.1.1. By Nanoparticle Type
9.3.5.2.2. By Application
9.3.5.2.3. By Disease Indication
9.3.6. Malaysia Nanomedicine Market Outlook
9.3.6.1. Market Size & Forecast
9.3.6.1.1. By Value
9.3.6.2. Market Share & Forecast
9.3.6.2.1. By Nanomolecule Type
9.3.6.2.1.1. By Nanoparticle Type
9.3.6.2.2. By Application
9.3.6.2.3. By Disease Indication
9.3.7. Vietnam Nanomedicine Market Outlook
9.3.7.1. Market Size & Forecast
9.3.7.1.1. By Value
9.3.7.2. Market Share & Forecast
9.3.7.2.1. By Nanomolecule Type
9.3.7.2.1.1. By Nanoparticle Type
9.3.7.2.2. By Application
9.3.7.2.3. By Disease Indication
10. South America Nanomedicine Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)
10.2.1.1. By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others)
10.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)
10.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Nanomedicine Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Nanomolecule Type
10.3.1.2.1.1. By Nanoparticle Type
10.3.1.2.2. By Application
10.3.1.2.3. By Disease Indication
10.3.2. Argentina Nanomedicine Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Nanomolecule Type
10.3.2.2.1.1. By Nanoparticle Type
10.3.2.2.2. By Application
10.3.2.2.3. By Disease Indication
10.3.3. Colombia Nanomedicine Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Nanomolecule Type
10.3.3.2.1.1. By Nanoparticle Type
10.3.3.2.2. By Application
10.3.3.2.3. By Disease Indication
11. Middle East and Africa Nanomedicine Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)
11.2.1.1. By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others)
11.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)
11.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)
11.2.4. By Country
11.3. Middle East and Africa: Country Analysis
11.3.1. Turkey Nanomedicine Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Nanomolecule Type
11.3.1.2.1.1. By Nanoparticle Type
11.3.1.2.2. By Application
11.3.1.2.3. By Disease Indication
11.3.2. Israel Nanomedicine Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Nanomolecule Type
11.3.2.2.1.1. By Nanoparticle Type
11.3.2.2.2. By Application
11.3.2.2.3. By Disease Indication
11.3.3. South Africa Nanomedicine Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Nanomolecule Type
11.3.3.2.1.1. By Nanoparticle Type
11.3.3.2.2. By Application
11.3.3.2.3. By Disease Indication
11.3.4. Saudi Arabia Nanomedicine Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Nanomolecule Type
11.3.4.2.1.1. By Nanoparticle Type
11.3.4.2.2. By Application
11.3.4.2.3. By Disease Indication
11.3.5. UAE Nanomedicine Market Outlook
11.3.5.1. Market Size & Forecast
11.3.5.1.1. By Value
11.3.5.2. Market Share & Forecast
11.3.5.2.1. By Nanomolecule Type
11.3.5.2.1.1. By Nanoparticle Type
11.3.5.2.2. By Application
11.3.5.2.3. By Disease Indication
11.3.6. Kuwait Nanomedicine Market Outlook
11.3.6.1. Market Size & Forecast
11.3.6.1.1. By Value
11.3.6.2. Market Share & Forecast
11.3.6.2.1. By Nanomolecule Type
11.3.6.2.1.1. By Nanoparticle Type
11.3.6.2.2. By Application
11.3.6.2.3. By Disease Indication
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends and Developments
14. Competitive Landscape
14.1. Pfizer Inc.
14.2. Janssen Pharmaceuticals
14.3. Sanofi S.A.
14.4. Amgen Inc.
14.5. Moderna, Inc.
14.6. Novo Nordisk A/S
14.7. Genentech, Inc
14.8. Celgene Corporation
14.9. Vifor Pharma Ltd.
14.10. Teva Pharmaceutical Industries Ltd.
15. Strategic Recommendations

Report Title: Global Nanomedicine Market, By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes), By Nanoparticle Type (Polymer-based, Lipid-based, Nanocrystals, Inorganic, Others), By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others) By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others), By Region and Competition Forecast & Opportunities, 2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW